Evaluation of the Crohn's Disease Activity Index (CDAI) and the Dutch Index for severity and activity of Crohn's disease. An analysis of the data from the European Cooperative Crohn's Disease Study
- PMID: 2233586
Evaluation of the Crohn's Disease Activity Index (CDAI) and the Dutch Index for severity and activity of Crohn's disease. An analysis of the data from the European Cooperative Crohn's Disease Study
Abstract
In the European Cooperative Crohn's Disease Study a general documentation of clinical and laboratory data was made at the entry into the study in 452 patients. These patients were in different states of their disease from quiescent to very active. In all patients the Crohn's Disease Activity Index of Best (CDAI) and the Dutch Index of van Hees was calculated. Three gastroenterologists did a global clinical rating and a separate laboratory rating without knowledge of the indices. The ratings were then correlated with the indices in the individual patients. The clinical rating correlated well with the CDAI (r = 0.88) and less with the Dutch Index (r = 0.672). On the other hand the laboratory rating showed a better correlation with the Dutch Index (r = 0.742) than with the CDAI (r = 0.573). This demonstrates that the CDAI preferably is an estimate of the clinical severity of the disease and not of the activity of inflammation. Vice versa the Dutch Index is mainly reflecting the activity of the inflammatory process.
Similar articles
-
[Value of C-reactive protein in the evaluation of activity in ulcerative colitis and Crohn's disease].Lijec Vjesn. 1990 Sep-Oct;112(9-10):281-4. Lijec Vjesn. 1990. PMID: 2093781 Croatian.
-
Assessment of disease activity in a registry of Crohn's disease patients in eastern Pennsylvania.Z Gastroenterol. 1991 Aug;29(8):378-82. Z Gastroenterol. 1991. PMID: 1950050
-
Defining the optimal response criteria for the Crohn's disease activity index for induction studies in patients with mildly to moderately active Crohn's disease.Am J Gastroenterol. 2008 Dec;103(12):3123-31. doi: 10.1111/j.1572-0241.2008.02176.x. Am J Gastroenterol. 2008. PMID: 18786111 Clinical Trial.
-
Assessment of inflammatory activity in Crohn's disease.Neth J Med. 1994 Aug;45(2):52-4. Neth J Med. 1994. PMID: 7936005 Review.
-
[Inflammatory bowel disease activity index: clinical and laboratory indicators].Arq Gastroenterol. 1995 Jul-Sep;32(3):121-30. Arq Gastroenterol. 1995. PMID: 8728787 Review. Portuguese.
Cited by
-
Mindfulness-based cognitive therapy for inflammatory bowel disease patients: findings from an exploratory pilot randomised controlled trial.Trials. 2015 Aug 25;16:379. doi: 10.1186/s13063-015-0909-5. Trials. 2015. PMID: 26303912 Free PMC article. Clinical Trial.
-
The use of mindfulness-based cognitive therapy for improving quality of life for inflammatory bowel disease patients: study protocol for a pilot randomised controlled trial with embedded process evaluation.Trials. 2013 Dec 17;14:431. doi: 10.1186/1745-6215-14-431. Trials. 2013. PMID: 24341333 Free PMC article. Clinical Trial.
-
Assessment of inflammatory activity in Crohn's disease by means of dynamic contrast-enhanced MRI.Radiol Med. 2007 Sep;112(6):798-809. doi: 10.1007/s11547-007-0192-y. Epub 2007 Sep 20. Radiol Med. 2007. PMID: 17885739 English, Italian.
-
Enhanced absorption of macromolecules. A secondary factor in Crohn's disease.Dig Dis Sci. 1996 Jul;41(7):1423-8. doi: 10.1007/BF02088568. Dig Dis Sci. 1996. PMID: 8689920
-
Infliximab treatment for Crohn's disease.Postgrad Med J. 2001 Jul;77(909):436-40. doi: 10.1136/pmj.77.909.436. Postgrad Med J. 2001. PMID: 11423591 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Medical